Tumor Markers in Lung Cancer
NCT01274468 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2012-08-10
Summary
The aim of this study is to determine if DCAMLK1 can be measured in the endobronchial biopsy specimens and bronchial washings from patients with lung cancer.
Conditions
Sponsors & Collaborators
-
University of Oklahoma
lead OTHER
Principal Investigators
-
Gary T Kinasewitz, MD · OU Health Sciences Center
Eligibility
- Min Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-08-31
- Primary Completion
- 2010-08-31
- Completion
- 2010-08-31
Countries
- United States
Study Locations
More Related Trials
-
Biomarker Discovery in Lung Cancer - Malaysia
NCT06504927 ·Status: RECRUITING
-
Detection of Genetic Markers of Lung Cancer
NCT00280202 ·Status: RECRUITING
-
Biomarker Discovery and Validation in Lung Cancer
NCT01147562 ·Status: UNKNOWN ·Phase: NA
-
DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma
NCT06477211 ·Status: COMPLETED
-
The Detection of Circulating Tumor Cells (CTCs) in Patients With Lung Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02412384 ·Status: COMPLETED
-
DNA Analysis of Blood and Tissue from Patients with Lung Cancer
NCT00471978 ·Status: RECRUITING
-
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
NCT00899028 ·Status: COMPLETED
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Survival Outcomes of Lung Cancer
NCT03647098 ·Status: RECRUITING
-
Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers
NCT00899262 ·Status: UNKNOWN
-
The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer
NCT02380196 ·Status: COMPLETED
-
Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
NCT04814407 ·Status: RECRUITING
-
Liquid Biopsy in Lung Cancer
NCT03479099 ·Status: COMPLETED
-
Study of Tumor Samples From Patients With Lung Cancer
NCT00900328 ·Status: COMPLETED
-
Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
NCT01141686 ·Status: COMPLETED
-
Study on Systemic and Airway Cytokines and Oxidative Stress in Lung Cancer Patients Undergoing Surgery
NCT00956852 ·Status: TERMINATED
-
Multiplex Analysis of Circulating Tumor DNA
NCT03301961 ·Status: UNKNOWN
-
Liverpool Lung Project: Risk Factors and Genetic Markers in Healthy Participants and Patients With Lung Cancer
NCT00503958 ·Status: UNKNOWN
-
Lifestyle Modification Program for Lung Cancer Patients - A Pilot Study
NCT04105647 ·Status: UNKNOWN ·Phase: NA
-
Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer
NCT01052818 ·Status: UNKNOWN
-
Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants
NCT00899457 ·Status: COMPLETED
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
A Preliminary Study on the Detection of Plasma Markers in Early Diagnosis for Lung Cancer
NCT04558255 ·Status: UNKNOWN
-
Monitoring the Changes of Tumor-related Biomarkers Before and After Pulmonary Nodule Biopsy.
NCT03397355 ·Status: UNKNOWN
-
A Study in Non-Small Cell Lung Cancer
NCT07174388 ·Status: RECRUITING